| Literature DB >> 25414484 |
Violeta Gomez-Rodriguez1, Josune Orbe1, Esther Martinez-Aguilar1, Jose A Rodriguez1, Leopoldo Fernandez-Alonso1, Jens Serneels1, Miriam Bobadilla1, Ana Perez-Ruiz1, Maria Collantes1, Massimiliano Mazzone1, Jose A Paramo2, Carmen Roncal2.
Abstract
We studied the role of matrix metalloproteinase-10 (MMP-10) during skeletal muscle repair after ischemia using a model of femoral artery excision in wild-type (WT) and MMP-10 deficient (Mmp10(-/-)) mice. Functional changes were analyzed by small animal positron emission tomography and tissue morphology by immunohistochemistry. Gene expression and protein analysis were used to study the molecular mechanisms governed by MMP-10 in hypoxia. Early after ischemia, MMP-10 deficiency resulted in delayed tissue reperfusion (10%, P < 0.01) and in increased necrosis (2-fold, P < 0.01), neutrophil (4-fold, P < 0.01), and macrophage (1.5-fold, P < 0.01) infiltration. These differences at early time points resulted in delayed myotube regeneration in Mmp10(-/-) soleus at later stages (regenerating myofibers: 30 ± 9% WT vs. 68 ± 10% Mmp10(-/-), P < 0.01). The injection of MMP-10 into Mmp10(-/-) mice rescued the observed phenotype. A molecular analysis revealed higher levels of Cxcl1 mRNA (10-fold, P < 0.05) and protein (30%) in the ischemic Mmp10(-/-) muscle resulting from a lack of transcriptional inhibition by MMP-10. This was further confirmed using siRNA against MMP-10 in vivo. Our results demonstrate an important role of MMP-10 for proper muscle repair after ischemia, and suggest that chemokine regulation such as Cxcl1 by MMP-10 is involved in muscle regeneration. © FASEB.Entities:
Keywords: hypoxia; inflammation; matrix metalloproteinase; regeneration
Mesh:
Substances:
Year: 2014 PMID: 25414484 DOI: 10.1096/fj.14-259689
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191